Back to Search
Start Over
Low HDL-cholesterol: A strong predictor of glycemic response to glitazone treatment in patients with type 2 diabetes
- Source :
- Diabetes Research and Clinical Practice. 93:e44-e48
- Publication Year :
- 2011
- Publisher :
- Elsevier BV, 2011.
-
Abstract
- We performed a study in 102 people with type 2 diabetes aiming to determine "easy-to-use" predictive factors for glycemic response to glitazones. We found that low baseline HDL-cholesterol (
- Subjects :
- Adult
Blood Glucose
Male
medicine.medical_specialty
Low HDL-cholesterol
Endocrinology, Diabetes and Metabolism
education
Type 2 diabetes
Rosiglitazone
chemistry.chemical_compound
Endocrinology
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Humans
Prospective Studies
Prospective cohort study
Aged
Glycemic
Glycated Hemoglobin
Pioglitazone
business.industry
Cholesterol
Cholesterol, HDL
General Medicine
Middle Aged
medicine.disease
Diabetes Mellitus, Type 2
chemistry
Female
Thiazolidinediones
business
medicine.drug
Subjects
Details
- ISSN :
- 01688227
- Volume :
- 93
- Database :
- OpenAIRE
- Journal :
- Diabetes Research and Clinical Practice
- Accession number :
- edsair.doi.dedup.....5352d229d0a6f4d6bca6c27a17e762d0
- Full Text :
- https://doi.org/10.1016/j.diabres.2011.04.005